RGT 20.2% 33.5¢ argent biopharma limited

Ann: Sale of MGC Derma to Strategic Partner Cannaglobal Canada, page-52

  1. 359 Posts.
    lightbulb Created with Sketch. 31
    don't know why some people are pessimistic on this deal.

    IMO I thing it's a good deal:

    - no further burden of derma, no further marketing costs means focus on core operation;
    - C$2.5m of loan repayment owed to MXC by its new partner, MXC has option to be paid in cash;
    - C$1m cash to be received in 10 working days;
    - I pointed out previously that MXC should have learnt a lesson from VC deal and perform detailed due diligence work on its biz partner. In the ANN u can tell MXC has reiterated this. IMO MXC will receive the money and ship the CBD.
    - as for its partner Cannglobal, if you were their management or founder would you choose not to work hard and to succeed after u have paid C$1m cash plus put another C$2.5m liability on ur shoulder?

    think about the above. be patient.

    I didn't expect high. I posted previously that my best guess is a sale for equity of another company. now it turns out just like that.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.085(20.2%)
Mkt cap ! $16.21M
Open High Low Value Volume
41.5¢ 41.5¢ 33.5¢ $56.04K 154.5K

Buyers (Bids)

No. Vol. Price($)
1 59999 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 653 1
View Market Depth
Last trade - 16.10pm 22/08/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.